Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

Justin Taylor, Xiaoli Mi, Alexander V. Penson, Stella V. Paffenholz, Kelsey Alvarez, Allison Sigler, Stephen S. Chung, Raajit K. Rampal, Jae H. Park, Eytan M. Stein, Martin S. Tallman, Filiz Sen, Mithat Gönen, Omar Abdel-Wahab, Virginia M. Klimek

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences